The MHRA's new post-market surveillance requirements for medical device manufacturers with products on the UK market are intended to enhance patient safety and communications around any issues. Image ...
The overall aim of the MHRA's proposals are to reduce duplicative costs for device manufacturers and hasten market access. Image credit: Dave Hoeek via Shutterstock.com. · Medical Device Network · ...
The MHRA recently published an update on its plans for MedTech regulatory change. The update confirmed that the new framework will be introduced through four statutory instruments to update and ...
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a suite of guidance specifically designed to help medical device manufacturers understand and prepare for the new post-market ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published guidance to help medtech manufacturers comply with its updated postmarket surveillance (PMS) regulation, which goes into ...
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has published guidance on the interpretation and implementation of incoming changes to the postmarket surveillance (PMS) rules for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results